"Endoscopic Monitoring Key In ‘Treat-To-Target’ Approach For IBD" - Alex Young
Using a treat-to-target approach for managing inflammatory bowel disease can be an important tool for improving both short- and long-term outcomes, according to Marla Dubinsky, MD, chief of pediatric gastroenterology and hepatology at the Kravis Children’s Hospital at Mount Sinai and co-director of the Susan and Leonard Feinstein IBD clinical center at The Mount Sinai Hospital. In a presentation given at the Interdisciplinary Autoimmune Summit, Dr. Dubinsky argued that gastroenterologists should consider more objective measures like endoscopic disease monitoring and therapy modification in addition to patient-reported clinical outcomes to avoid the eventual progression to the development of serious complications in IBD. “Yes, your patient needs to feel well, but they also have to have endoscopic remission,” Dr. Dubinsky said. “At the time of colonoscopy, they have to have normalization. That is a big change in just asking a patient how they’re doing.”
- Marla C. Dubinsky, MD, Professor, Pediatrics, Gastroenterology, Icahn School of Medicine at Mount Sinai, Chief, Pediatric Gastroenterology and Hepatology, Kravis Children’s Hospital at Mount Sinai, Co-Director, The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center, Mount Sinai Hospital